|
|
Department of Clinical Oncology, City Hospital,
Hucknall Road, Nottingham NG5 1PB United Kingdom
phone:0115 823 1863
fax:0115 823 1863
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.scancell.co.uk
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Monoclonal antibodies and vaccines for the treatment of cancer. |
|
| Management |
| Professor Lindy Durrant, CEO; Dr Richard Goodfellow, Commercial Director |
| |
|
|
| |
|
| Keywords |
| monoclonal, antibodies, vaccines, cancer, apoptosis, lung, antibody, radioisotopes, toxin, conjugate, immune, humoral, cytotoxic, t-cell |
|
|
|
| Description |
|
Scancell is a privately held company that develops monoclonal antibodies and vaccines for the treatment of cancer. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members